你好,欢迎访问上海交通大学附属第一人民医院公济文库!
所在位置: 首页 - 科室团队导航 - 肿瘤临床医学中心
相关导航
按语种分组
  • 任何
  • 413 中文
  • 372 外文
年代
  • 任何
  • 49 2021
  • 90 2020
  • 60 2019
  • 63 2018
  • 58 2017
  • 45 2016
  • 35 2015
  • 34 2014
  • 18 2013
  • 22 2012
  • 34 2011
  • 18 2010
  • 214 2000-2009
  • 41 1990-1999
按类型分组
  • 任何
  • 366 中文期刊
  • 362 外文期刊
  • 27 中文会议论文
  • 18 中文专利
  • 9 外文专利
  • 更多
按重要期刊分组
  • 任何
  • 315 SCI科学引文索引(美)
  • 261 国内统计源期刊
  • 250 SCIE
  • 213 CSCD中国科学引文库
  • 181 CA化学文摘(美)
  • 更多
按来源刊物分组
  • 任何
  • 23 中国癌症杂志
  • 17 肿瘤
  • 16 中华眼科杂志
  • 13 现代生物医学进展
  • 12 Annals of Onc
  • 更多
科室简介: 成果数量:785

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医... [详细]

本科室知名学者:
本科室科研趋势: 发文数量 期刊收录
条数据
导出

作者: Guo Z;Sun L;Li B;Tian R;Zhang X;Zhang Z;Clifford SP;Liu Y;Huang J;Li X (Affiliations 1 Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. 2 Department of Cardiovascular Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China. 3 Department of Emergency and Critical Care, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China. 4 Department of Intensive Care Unit, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. 5 Department of Intensive Care Unit, Fudan University Shanghai Cancer Center, Shanghai, China. 6 Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY. 7 Department of Statistics Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. 8 Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY. Electronic address: jiapeng.huang@louisville.edu. 9 Department of Cardiovascular Surgery. Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: li.xin3@zs-hospital.sh.cn.)

出处: Journal of cardiothoracic and vascular anesthesia 2021 Vol.35 No.2 P389-397

关键词: COVID-19;ECMO;SARS-CoV-2;anticoagulation;coronavirus;extracorporeal membrane oxygenation;severe acute respiratory syndrome coronavirus 2;thrombosis.

摘要: Objective: To explore special coagulation characteristics and anticoagulation management in extracorporeal membrane oxygenation (ECMO)-assisted patien ...

作者: Zhen Guo MD;Lin Sun MD;Bailing Li MD;Rui Tian MD;Xiaolin Zhang MD;Zhongwei Zhang MD;Sean P. Clifford MD;Yuan Liu BS;Jiapeng Huang MD, PhD;Xin Li MD (7 Department of Statistics Center, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai China 8 Department of Cardiovascular Surgery. Zhongshan Hospital, Fudan University, Shanghai China 5 Department of Intensive Care Unit, Fudan University Shanghai Cancer Center, Shanghai China 6 Department of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA 3 Department of Emergency and Critical Care, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai China 4 Department of Intensive Care Unit, Shanghai Public Health Clinical Center, Fudan University, Shanghai China 1 Department of Cardiovascular Surgery. Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai China 2 Department of Cardiovascular Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai China)

出处: Journal of Cardiothoracic and Vascular Anesthesia 2021

关键词: COVID-19;Coronavirus;SARS-CoV-2;extracorporeal membrane oxygenation;anticoagulation;thrombosis;ECMO

摘要: Objective To explore special coagulation characteristics and anticoagulation management in extracorporeal membrane oxygenation assisted patients with ...

作者: Ran Cui  1   2 , Ying Zhu  3 , Yulan Wang  4 , Xiao-Hua Chen  2   5 , Qiang Li  6 , Sheng-Ming Dai  1 , Qiang Tong  1 (Affiliations 1 Department of Rheumatology & Immunology, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China. 2 Department of Infectious Diseases, Wuhan Leishenshan Hospital, Wuhan, Hubei, China. 3 Department of Respiratory & Critical Care Medicine, Seventh Medical Center of Chinese PLA General Hospital, Beijing, China. 4 Molecular Diagnostic Laboratory of Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 5 Department of Infectious Diseases, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, Shanghai, China. 6 Department of Respiratory & Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medical, Shanghai, China.)

出处: Future virology 2021 Vol.16 No.5 P321-329

关键词: COVID-19;IL-6;IL-6 receptor;IL-6R antagonists;SARS-CoV-2;adverse events;cytokine release syndrome;inflammatory response;mortality;tocilizumab.

摘要: Aim: Coronavirus disease 2019 is a life-threatening disease and how to improve survival of the patients is of great importance. Objective: To determin ...

作者: Tongde Wu  1 , Xuebing Jia  2 , Hang Feng  3 , Desheng Wu  4 (Affiliations 1 Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine, 150 Jimo Rd, Shanghai, 200120, China. 2 Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. 3 Department of Surgery of Spine and Spinal Cord, Henan Provincial People\'s Hospital, People\'s Hospital of Zhengzhou University, Zhengzhou, 450003, Henan, China. 4 Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine, 150 Jimo Rd, Shanghai, 200120, China. Electronic address: eastspinewudesheng@126.com.)

出处: Biochemical and biophysical research communications 2021 Vol.545 P54-61

关键词: ACTG1;Akt;Apoptosis;Inflammation;Intervertebral disc degeneration;NF-κB.

摘要: ACTG1 is a member of the actin family but is not a muscle actin gene. The ACTG1 mutation leads to hearing loss in humans, and the knockdown of ACTG1 s ...

作者: Liu Yang1;Xiaowei Yan2;Jie Chen3;Qiong Zhan4;Yingqi Hua1;Shili Xu5;Ziming Li6;Zhuo Wang7,8;Yu Dong3;Dongqing Zuo1;Min Xue8;Yin Tang2;Herschman, Harvey R5;Shun Lu6;Qihui Shi7,8;Wei Wei2,5 (1 Department of Orthopedics, Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China 2 Institute for Systems Biology, Seattle, WA 98109 3 Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China 4 Department of Oncology, Huashan Hospital, Fudan University, Shanghai, 200040, China 5 Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 6 Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China 7 Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China 8 Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer (SMHC), Minhang Hospital, Fudan University, Shanghai, 201199, China)

出处: Proceedings of the National Academy of Sciences of the United States of America 2021 Vol.118 No.11 P1-11

关键词: circulating tumor cells;hexokinase-2;liquid biopsy;non-small cell lung cancer;single-cell sequencing

摘要: Unlike other epithelial cancer types, circulating tumor cells (CTCs) are less frequently detected in the peripheral blood of non-small cell lung cance ...

作者: Huairong Zhang #  1   2   3 , Andrea Liliam Gomez Corredor #  2 , Julia Messina-Pacheco #  2 , Qing Li  4 , George Zogopoulos  5 , Nancy Kaddour  6 , Yifan Wang  5 , Bing-Yin Shi  3 , Alex Gregorieff  2 , Jun-Li Liu  7 , Zu-Hua Gao  8 (Affiliations 1 Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2 Department of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. 3 Department of Endocrinology, The First Affiliated Hospital of Xi\'an Jiaotong University, Xi\'an, Shaanxi, China. 4 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. 5 Department of Surgery, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. 6 Department of Medicine, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. 7 Department of Medicine, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. jun-li.liu@mcgill.ca. 8 Department of Pathology, McGill University and the Research Institute of McGill University Health Centre, Montreal, QC, Canada. zu-hua.gao@mcgill.ca.)

出处: Communications biology 2021 Vol.4 No.1 P688

关键词: PANCREATIC-CANCER PROGRESSION;UP-REGULATION;CELL-GROWTH;PROTEIN;REG3A;OVEREXPRESSION;REG3-BETA;MICE;DIFFERENTIATION;REGENERATION

摘要: Persistent acinar to ductal metaplasia (ADM) is a recently recognized precursor of pancreatic ductal adenocarcinoma (PDAC). Here we show that the ADM ...

作者: Yun Liu  1   2   3 , Honglian Wang  4 , Xin Wang  5 , Jiaqi Liu  5 , Junjian Li  1 , Xiang Wang  5 , Yun Zhang  6   7 , Zhigang Bai  6   7 , Qinghua Zhou  8 , Ying Wu  8 , Yi Shen  8 , Xiaoling Weng  2   3 , Fatao Liu  9 , Jiancheng Guo  10 , Lijun Di  11 , Olivier Gires  12 , Zhongtao Zhang  13 , Yiding Chen  14   15 , Hongxia Wang  16 (Affiliations 1 State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, China. 2 State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 3 Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 4 AITA Biomedical Research Institute, Shanghai, China. 5 Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 6 Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, 95 Yong\'an Road, Beijing, China. 7 Beijing Key Laboratory of Cancer Invasion and Metastasis Research and National Clinical Research Center for Digestive Diseases, Beijing, China. 8 Department of Surgery, Luwan Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 9 Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China. 10 Center for Precision Medicine, Zhengzhou University School of Medicine, Zhengzhou, China. 11 Cancer Center, Faculty of Health Science, University of Macau, Macau, China. 12 Department of Otorhinolaryngology, Grosshadern Medical Center, Ludwig Maximilians University of Munich, Munich, Germany. 13 Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, 95 Yong\'an Road, Beijing, China. zhangzht@ccmu.edu.cn. 14 Department of Surgical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, China. ydchen@zju.edu.cn. 15 The Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Hangzhou, Zhejiang, China. ydchen@zju.edu.cn. 16 State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, China. whx365@126.com.)

出处: Journal of hematology & oncology 2021 Vol.14 No.1 P18

关键词: BRCA1/2;Breast cancer;Cohort;Reclassification;VUS.

摘要: Accurate interpretation of BRCA1/2 variants is critical for risk assessment and precise treatment of breast cancer (BC). Hence, the establishment of a ...

作者: Xuan Lin  1   2   3   4, Longyun Ye  1   2   3   4, Xu Wang  1   2   3   4, Zhenyu Liao  1   2   3   4, Jia Dong  1   2   3   4, Ying Yang  1   2   3   4, Rulin Zhang  5, Hao Li  1   2   3   4, Pengcheng Li  1   2   3   4, Lei Ding  1   2   3   4, Tianjiao Li  1   2   3   4, Wuhu Zhang  1   2   3   4, Shuaishuai Xu  1   2   3   4, Xuan Han  1   2   3   4, Huaxiang Xu  1   2   3   4, Wenquan Wang  1   2   3   4, Heli Gao  1   2   3   4, Xianjun Yu  1   2   3   4, Liang Liu  1   2   3   4 (Affiliations 1 Department of Pancreatic Surgery, Shanghai Cancer Center, Fudan University, Shanghai 200032, China. 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. 3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, China. 4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China. 5 Department of Laboratory Medicine, Shanghai General Hospital, Shanghai 200080, China.)

出处: Cancers 2021 Vol.13 No.15 P3678

关键词: follicular helper T cells;immune microenvironment;immunosuppression;neoadjuvant chemotherapy;pancreatic ductal adenocarcinoma.

摘要: Immunosuppression is an important factor for the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Follicular helper T cells (Tfh cells) play ...

作者: Senlin Zhao1,2;Bingjie Guan3;Yushuai Mi4;Debing Shi1,2;Ping Wei2,5,6;Yanzi Gu7;Sanjun Cai1,2;Ye Xu1,2;Xinxiang Li1,2;Dongwang Yan3;Mingzhu Huang2,8& Dawei Li1,2 (Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China Senlin Zhao, Debing Shi, Sanjun Cai, Ye Xu, Xinxiang Li & Dawei Li <<#>> Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China Senlin Zhao, Debing Shi, Ping Wei, Sanjun Cai, Ye Xu, Xinxiang Li, Mingzhu Huang & Dawei Li <<#>> Department of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China Bingjie Guan & Dongwang Yan <<#>> Department of Gastrointestinal Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China Yushuai Mi <<#>> Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China Ping Wei <<#>> Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China Ping Wei <<#>> Department of Biobank, Fudan University Shanghai Cancer Center, Shanghai, China Yanzi Gu <<#>> Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China Mingzhu Huang)

出处: Oncogene 2021 Vol.40 P4709-4724

摘要: Glycolysis plays a crucial role in reprogramming the metastatic tumor microenvironment. A series of lncRNAs have been identified to function as oncoge ...

作者: Xisheng Liu #  1 , Xiaole Meng #  2 , Xiao Peng #  3 , Qianlan Yao #  4   5 , Fangming Zhu  6 , Zhongyi Ding  7 , Hongze Sun  1 , Xueni Liu  1 , Dan Li  8 , Ying Lu  9 , Huamei Tang  10 , Bin Li  11 , Zhihai Peng  12   13 (Affiliations 1 Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2 Organ Transplantation Institute of Xiamen University, Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Xiamen University, Xiamen, China. 3 Department of Biology, Temple University, Philadelphia, PA, USA. 4 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. 5 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 6 Department of Microbiology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 7 Laboratory Animal Center, Institute Pasteur of Shanghai, University of Chinese Academy of Sciences, Shanghai, China. 8 Shanghai Institute of Immunology and Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 9 Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 10 Department of Pathology, Xiang\'an Hospital of Xiamen University, Xiamen, China. tanghuamei2014@163.com. 11 Shanghai Institute of Immunology and Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. binli@shsmu.edu.cn. 12 Organ Transplantation Institute of Xiamen University, Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Xiamen University, Xiamen, China. pengzhihai1958@163.com. 13 Hepatobiliary and Pancreatic & Organ Transplantation Surgery Department, Xiang\'an Hospital of Xiamen University, Xiamen, China. pengzhihai1958@163.com.)

出处: Cell death & disease 2021 Vol.12 No.4 P390

摘要: Increasing evidence suggests that global downregulation of miRNA expression is a hallmark of human cancer, potentially due to defects in the miRNA pro ...

肿瘤临床医学中心简介

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医师。目前,肿瘤中心下设肿瘤内科、肿瘤放疗科、肿瘤介入科、肿瘤基因诊断及生物治疗科。目前肿瘤中心核定床位数185张,科室现有医技人员共50人,其中医生36人,正高级职称7人,副高级职称9人,中级职称18人,具有博士学历11人,硕士学历18人,博士研究生导师3人,硕士研究生导师5人;5人曾在国外进修学习,2人目前正在国外学习。肿瘤中心现为中国抗癌协会临床肿瘤学会(CSCO)执行委员会单位,CSCO胰腺癌专家委员会主任委员单位、CSCO抗肿瘤药物安全管理委员会委员单位、上海市抗癌协会理事单位、上海市医学会肿瘤专科委员会副主任委员单位、上海市肿瘤放射治疗专业委员会委员单位、上海市肿瘤化疗质控中心专家委员单位、上海市肿瘤放疗质控专家委员会单位。
2013年,经全院肿瘤相关专科共同努力,肿瘤中心入选国家临床重点专科建设项目,建设经费500万元。近3年,获得国家级课题(含国家自然科学基金重大研究计划、国家“973”“863”计划、重大国际合作)17项(仅2015年获得国家自然科学基金9项)、市级课题10项,各类科研经费2500余万元。在《Nature Medicine》、《Gastroenterology》等杂志发表高质量SCI论文。在胰腺癌的基础研究与临床诊治方面在上海市乃至全国颇具影响,主持编写了《胰腺癌患者健康教育手册》、中国首部《胰腺癌综合诊治中国专家共识》,为上海市胰腺疾病重点实验室及上海交通大学胰腺癌诊治中心。在人才培养方面,1人入选国家杰出青年基金计划、1人入选“百千万人才工程”国家级人选、1人入选上海市医学领军人才、1人入选上海市优秀学科带头人计划、3人入选上海市“浦江人才计划”。
2013年成立了肿瘤诊治中心以来,肿瘤学科得到迅猛发展。中心集肿瘤预防、诊断、综合治疗和康复为一体,能开展各项专科项目并形成如下医疗特色:
1.肿瘤个体化化疗、靶向治疗、免疫治疗:根据每位患者独特的基因表达情况,制定个体化的化疗方案,联合靶向治疗,极大提高了结直肠癌、肺癌、乳腺癌、胃癌等治疗效果。
2.精准放疗:目前拥有直线加速器3台,其中包括最先进的VARIAN-RapidArc治疗系统,实现了对实体肿瘤的精准放疗。现已开展三维适形放射治疗、调强适形放射治疗、图像引导下的三维适形调强放疗、同步放化疗、PET-CT引导下放疗、立体定向放射治疗等。
3.肿瘤微创治疗:在上海市开展了首例纳米刀治疗局部晚期胰腺癌,还包括高强度超声聚焦治疗系统(HIFU刀)、射频/微波肿瘤消融治疗系统、高频热疗系统、放射性粒子组织间植入治疗系统、氩氦刀低温冷冻肿瘤治疗系统、血管介入等技术,适用于治疗肝癌、肺癌等实体肿瘤。
4.肿瘤分子诊断:包括免疫功能检测、EGFR、K-ras、BRAF等基因突变检测,Her-2基因扩增检测,循环血肿瘤细胞检测等,为肿瘤患者个体化治疗与靶向治疗选择,以及预后判断,提供了更准确的方法。
5.开设肿瘤多学科联合诊治:多学科、多专家共同参与,为患者制定个体化、综合治疗方案,实现对每位肿瘤患者的全称管理,为肿瘤患者提供最科学的诊断治疗技术和最优质的一站式服务。
6.肿瘤生物治疗:全国率先开展生物免疫治疗与现有传统治疗手段(化疗、放疗)综合治疗实体肿瘤(胰腺癌、乳腺癌等),开展单病种肿瘤生物免疫治疗临床研究多项,通过规范病例入组,规范细胞制备与使用,规范疗效评价,并建立相应的疗效评估体系及规范。
7.新药临床研究:在医院药物临床研究机构的监督下,牵头、参与国际多中心临床研究,为结直肠癌、胰腺癌、乳腺癌、胃癌、肺癌等患者提供最新的药物治疗。
8.中心静脉置管及护理: 1999年我科成功置入上海市第一根PICC导管,开创了护士进 行中心静脉置管的新篇章。2006年引入PORT技术,2007年在全国率先开展非超声引导下塞丁格(MST)穿刺技术,2009年引入B超引导下置管技术,新技术的引进提高了PICC置管成功率,解决了临床实际问题。
目前,肿瘤中心的主要研究方向有:胰腺癌的临床及基础研究、胰腺癌炎-癌转化的基础研究、乳腺癌的基础与临床转化研究、三阴性乳腺癌的精准与免疫治疗研究、肿瘤放疗后再增殖研究、肺癌基础研究、转录因子对肝癌发生发展影响的机制研究、基因多态性与化疗敏感性的临床研究、血药浓度检测与化疗敏感性的临床研究等。"